The weekly litigation news digest is live. Subscribe now

IP Verse

Loxo Oncology competitive analysis

Loading summary...

Latest patents of Loxo Oncology opposed by its competitors

Explore Loxo Oncology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 4, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3439662
Jul 24, 2024Liquid Formulations Of (S)-N-(5-((R)-2-(2,5-Difluorophenyl)-Pyrrolidin-1-Yl)-Pyrazolo[1,5-A]Pyrimidin-3-Yl)-3-Hydroxypyrrolidine-1-Carboxamide1

Latest PTAB cases involving Loxo Oncology

Discover the latest PTAB cases involving Loxo Oncology, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Loxo Oncology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 4, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LOXO ONCOLOGY - 1 - -
SYNTHON3316 - -